Kinetics of Biomarkers of Oxidative Stress in Septic Shock: A Pilot Study

Varování

Publikace nespadá pod Filozofickou fakultu, ale pod Lékařskou fakultu. Oficiální stránka publikace je na webu muni.cz.
Autoři

HELÁN Martin MALÁSKA Jan TOMANDL Josef JARKOVSKÝ Jiří HELÁNOVÁ Kateřina BENEŠOVÁ Klára ŠITINA Michal DASTYCH Milan ONDRÚŠ Tomáš PÁVKOVÁ GOLDBERGOVÁ Monika GÁL Roman LOKAJ Petr TOMANDLOVÁ Marie PAŘENICA Jiří

Rok publikování 2022
Druh Článek v odborném periodiku
Časopis / Zdroj Antioxidants
Fakulta / Pracoviště MU

Lékařská fakulta

Citace
www https://www.mdpi.com/2076-3921/11/4/640
Doi http://dx.doi.org/10.3390/antiox11040640
Klíčová slova sepsis; septic shock; oxidative stress; antioxidant; biomarker; soluble endoglin; superoxide dismutase; asymmetric dimethylarginine; neopterin
Popis Septic shock is a major cause of mortality in ICU patients, its pathophysiology is complex and not properly understood. Oxidative stress seems to be one of the most important mechanisms of shock progression to multiple organ failure. In the present pilot study, we have analysed eight oxidative-stress-related biomarkers in seven consecutive time points (i.e., the first seven days) in 21 septic shock patients admitted to the ICU. Our objective was to describe the kinetics of four biomarkers related to pro-oxidative processes (nitrite/nitrate, malondialdehyde, 8-oxo-2'-deoxyguanosine, soluble endoglin) compared to four biomarkers of antioxidant processes (the ferric reducing ability of plasma, superoxide dismutase, asymmetric dimethylarginine, mid-regional pro-adrenomedullin) and four inflammatory biomarkers (CRP, IL-6, IL-10 and neopterin). Furthermore, we analysed each biomarker’s ability to predict mortality at the time of admission and 12 h after admission. Although a small number of study subjects were recruited, we have identified four promising molecules for further investigation: soluble endoglin, superoxide dismutase, asymmetric dimethylarginine and neopterin.
Související projekty:

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.